A sampling of media coverage that profiles or mentions CCRM
OmniaBio: Ready for the Global Biomanufacturing Boom. ISCT Telegraft Hub, November 2022 issue.
Avectas Expands Collaboration with CCRM and OmniaBio Inc. Contract Pharma, November 30, 2022.
Resolution Therapeutics and CCRM Enter Research Collaboration. Contract Pharma, November 11, 2022.
Toronto and Minnesota health ecosystems offer great promise for Finnish companies. Health Capital Helsinki website, November 7, 2022.
Vancouver is ready to foster the next generation of biotech companies. Vancouver Tech Journal, October 27, 2022.
Government Engagement Bodes Well For [Canadian] Life Sciences. Market Screener, October 26, 2022.
Catching up with Hamilton: A city on the move. Real Estate News Exchange, October 24, 2022.
NGen appuie la fabrication commerciale de thérapies cellulaires et géniques au Canada. CScience, October 11, 2022.
Innovation and commercialization in Southern Ontario. Synapse Consortium Brochure, Page 21. October 6, 2022.
Three ways smart site selection is helping life sciences companies turn innovation into commercialization. Investment Monitor, September 23, 2022.
CBRE Helps Launch Game-Changing Biomanufacturing Facility For Hamilton. CBRE website. September 7, 2022.
CCRM, A Premier Incubator of CGT Companies. Life Sciences Review, August 2022 issue.
Biotech boom: 4 ways stem cells are changing how we treat disease. MaRS Discovery District website. July 19, 2022.
CDL’s new global Advanced Therapies stream brings together industry leader CCRM, four top universities on two continents. Financial Post, June 30, 2022.
‘This is the future of medicine’: Centre for Commercialization of Regenerative Medicine CEO Michael May on bringing Canada’s life science discoveries to market. Toronto Star, June 25, 2022.
OmniaBio, Medipost Ink Acquisition and Investment Deal. Contract Pharma, June 7, 2022.
A Special Series Dedicated to Advances in Advanced Medicine. The Medicine Maker, May 27, 2022.
CATTI: Closing Canada’s biomanufacturing skills gap. BIOTECanada Insights, May 24, 2022.
Canada aims to get a slice of the growing global market for cell and gene therapies. Toronto Star, May 18, 2022.
Federal investment required to build a cell and gene therapy ecosystem in Canada, says Innovation Economy Council. Research Money, May 10, 2022.
AcCELLerate-ON awards $900K to four projects that put Canadian cellular agriculture on the map. Food Matters Live, May 6, 2022.
What’s a CDMO and why do biotech startups need them? Let’s ask Canada. Crunchbase News, May 5. 2022.
Healthcare Is a Cost. But It’s Also a Business Opportunity. Canadian Business, April 26, 2022.
Tech update: Using artificial intelligence to solve supply chain snarls, and consolidation in Canadian crypto. The Peterborough Examiner, April 22, 2022.
Canada should be manufacturing its own cell and gene therapies, not just vaccines. The Globe and Mail, April 11, 2022.
Ontario antes up $580M for C&G therapy plant in Hamilton. Endpoints News, April 1, 2022.
Gene therapy manufacturing coming to McMaster Innovation Park. The Bay Observer, April 1, 2022.
Ontario invests in $580 million gene and cell therapy facility in Hamilton. CHCH-TV, March 31, 2022.
New gene- and cell-therapy manufacturing facility to launch in Hamilton with $580-million commitment. The Globe and Mail, March 31, 2022.
WATCH: Ontario economic development minister to make announcement in Hamilton at 1:30 p.m. CHCH-TV, March 31, 2022.
How Sherif Sheta leads IT to keep Canada on life sciences’ cutting edge. CIO, February 24, 2022.
Canada’s Biomanufacturing Workforce. Manufacturing in Focus, February, 2022.
Hamilton needs manufacturing mojo. The Hamilton Spectator, February 13, 2022.
